Left Main Disease: What Is the Correct Approach to Revascularization?Rab, Tanveer, MD; King, Spencer B. III, MDCardiology in Review: September/October 2018 - Volume 26 - Issue 5 - p 219–229 doi: 10.1097/CRD.0000000000000213 Review Articles Abstract Author Information Percutaneous coronary intervention of the left main coronary artery has evolved through registries and meta analyses, supported by results from the EXCEL [Everolimus-Eluting Stents (EES) or Bypass Surgery for Left Main Coronary Artery Disease] and NOBLE (Percutaneous Coronary Angioplasty versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis) trials as an acceptable alternative to coronary artery bypass grafting in patients with low and intermediate Syntax scores. Advances in stenting strategies and the availability of larger diameter drug-eluting stents improve patient safety and optimize procedural and patient outcomes. From the Division of Cardiology, Emory University School of Medicine, Atlanta, GA. Disclosure: The authors declare no conflict of interest. Correspondence: Tanveer Rab, MD, Division of Cardiology, Emory University School of Medicine Atlanta, GA. E-mail: firstname.lastname@example.org. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.